Companies › Undecimal Bio
Undecimal Bio logo

Undecimal Bio

Ramat Gan, Israel · ≈10 employees · Research and Development in Biotechnology (except Nanobiotechnology) · undecimalbio.com

Undecimal Bio is a biotechnology company developing an AI-driven platform for targeted siRNA drug delivery.

Funding

1
Every round, secondary, debt facility or acquisition involving Undecimal Bio that AI Lounge tracks, newest first. Latest: Seed on Oct 12, 2026.

Timeline · 1

Oct 12, 2026
Round
Seed · $18M at $81M · 4BIO Capital, IQ Capital
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in